Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pfizer oncology R&D exec heads to Aduro as new CMO; Army dumps Tonix research contract
7 years ago
News Briefing
As rivals wait in line, Merck's Keytruda scores early FDA nod for frontline patients with the most common form of ...
7 years ago
R&D
Pharma
Watch out bluebird bio. A little biotech just got Novartis’ backing to break out of the back field and race you to ...
7 years ago
Financing
Cell/Gene Tx
Biotech vet Troy Wilson shines a spotlight on his oligonucleotide startup as Eli Lilly signs up for a premier Big ...
7 years ago
Financing
FDA approves the first generic for life-saving opioid overdose treatment naloxone that can be carried by untrained ...
7 years ago
Pharma
Jeff Aronin's startup incubator scoops ex-Alkermes exec Jim Robinson for new president/COO role
7 years ago
People
Novartis' star gene therapy faces potential safety issue following a recent infant death in study
7 years ago
Cell/Gene Tx
RIP tanezumab? Eli Lilly, Pfizer spotlight alarming safety data for NGF pain drug in PhIII
7 years ago
R&D
Peer Review: KSQ woos Beni Wolf from Blueprint with CRISPR platform; AstraZeneca exec jumps to CNS biotech spun out ...
7 years ago
Peer Review
Genfit wins BTD status at FDA for its lead drug for liver disease; Idorsia outlines $530M '19 spending plans on ...
7 years ago
News Briefing
Two gene therapy approvals headline CBER’s FY 2018 report
7 years ago
R&D
Penn scientists correct genetic flaw in mice fetuses, expanding in utero CRISPR reach to lung diseases
7 years ago
Discovery
Gilead-partnered Vienna-based immunotherapy company Hookipa makes Nasdaq debut with downsized $84M IPO
7 years ago
Financing
France's Sanofi contributes €10M to the restoration of Notre Dame
7 years ago
People
Gene therapy for 'bubble boy disease' sets stage for cure
7 years ago
Cell/Gene Tx
Serial biotech entrepreneur Michael Gilman takes his key to the $100M-plus club and goes all-in on drugging RNA
7 years ago
Financing
Startups
On a mission to make organ transplants safer and more durable, Blackstone gifts Talaris a new CEO, leads $100M round
7 years ago
Financing
Startups
GlaxoSmithKline R&D reorganization triggers layoffs at Stevenage -- and Upper Providence
7 years ago
R&D
Biotech startup grabs $27M launch round to pursue an R&D path blazed at Harvard and Boston Children’s
7 years ago
Startups
R&D
Turning Point unveils $166M IPO; Aquestive's riluzole film product is accepted for FDA review
7 years ago
News Briefing
In another CRISPR first, Penn researchers dose US cancer patients with gene-edited T cell therapy
7 years ago
Cell/Gene Tx
Fresh safety, tolerability data snapshot from early-stage study of Wave's DMD drug spooks investors
7 years ago
R&D
'Patients are not a company's resource': FDA cancer czar Richard Pazdur has a bone to pick with the top R&D execs in ...
7 years ago
People
R&D
Ned Sharpless is not playing with the FDA’s gold standard — any more than Scott Gottlieb did
7 years ago
People
Bioregnum
First page
Previous page
941
942
943
944
945
946
947
Next page
Last page
